Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0641
D

Failure to Complete Required Evaluation Before Antipsychotic Administration

Brownsville, Texas Survey Completed on 07-15-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that a resident received an accurate assessment prior to the administration of an antipsychotic medication. Record review showed that the resident, who had diagnoses including dementia without behavioral disturbance, psychotic disturbance, mood disturbance, anxiety, and a traumatic subdural hemorrhage, was not evaluated before being given Haldol Decanoate for aggressive behavior. The resident's admission MDS indicated severe cognitive impairment with no behavioral symptoms or indicators of psychosis, and there was no documentation of an evaluation prior to the initiation of the antipsychotic. Progress notes confirmed that the antipsychotic was ordered and administered without a prior psychiatric evaluation, and the care plan was updated to reflect the use of Haldol for agitation. Interviews with facility staff, including a physician assistant, LVN, and the DON, confirmed that an evaluation should have been completed before administering the medication, and that no such evaluation was documented. The facility's policy also required an evaluation and documentation prior to the use of psychotropic medications, which was not followed in this case.

An unhandled error has occurred. Reload 🗙